147 related articles for article (PubMed ID: 17045922)
1. Oxidized plasma high-density lipoprotein is decreased in Alzheimer's disease.
Bergt C; Nakano T; Ditterich J; DeCarli C; Eiserich JP
Free Radic Biol Med; 2006 Nov; 41(10):1542-7. PubMed ID: 17045922
[TBL] [Abstract][Full Text] [Related]
2. Myeloperoxidase-mediated oxidation of high-density lipoproteins: fingerprints of newly recognized potential proatherogenic lipoproteins.
Malle E; Marsche G; Panzenboeck U; Sattler W
Arch Biochem Biophys; 2006 Jan; 445(2):245-55. PubMed ID: 16171772
[TBL] [Abstract][Full Text] [Related]
3. Immunochemical detection of circulating oxidized high-density lipoprotein with antioxidized apolipoprotein A-I monoclonal antibody.
Nakano T; Nagata A
J Lab Clin Med; 2003 Jun; 141(6):378-84. PubMed ID: 12819635
[TBL] [Abstract][Full Text] [Related]
4. Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease.
Moradi H; Pahl MV; Elahimehr R; Vaziri ND
Transl Res; 2009 Feb; 153(2):77-85. PubMed ID: 19138652
[TBL] [Abstract][Full Text] [Related]
5. Increased low-density lipoprotein oxidation, but not total plasma protein oxidation, in Alzheimer's disease.
Aldred S; Bennett S; Mecocci P
Clin Biochem; 2010 Feb; 43(3):267-71. PubMed ID: 19733555
[TBL] [Abstract][Full Text] [Related]
6. Association between both lipid and protein oxidation and the risk of fatal or non-fatal coronary heart disease in a human population.
Woodward M; Croft KD; Mori TA; Headlam H; Wang XS; Suarna C; Raftery MJ; MacMahon SW; Stocker R
Clin Sci (Lond); 2009 Jan; 116(1):53-60. PubMed ID: 18507534
[TBL] [Abstract][Full Text] [Related]
7. Oxidized proteins in Alzheimer's plasma.
Conrad CC; Marshall PL; Talent JM; Malakowsky CA; Choi J; Gracy RW
Biochem Biophys Res Commun; 2000 Aug; 275(2):678-81. PubMed ID: 10964722
[TBL] [Abstract][Full Text] [Related]
8. Myeloperoxidase-mediated oxidation targets serum apolipoprotein A-I in diabetic patients and represents a potential mechanism leading to impaired anti-apoptotic activity of high density lipoprotein.
Lu N; Xie S; Li J; Tian R; Peng YY
Clin Chim Acta; 2015 Feb; 441():163-70. PubMed ID: 25528002
[TBL] [Abstract][Full Text] [Related]
9. Formation of dysfunctional high-density lipoprotein by myeloperoxidase.
Nicholls SJ; Zheng L; Hazen SL
Trends Cardiovasc Med; 2005 Aug; 15(6):212-9. PubMed ID: 16182131
[TBL] [Abstract][Full Text] [Related]
10. Haptoglobin binding to apolipoprotein A-I prevents damage from hydroxyl radicals on its stimulatory activity of the enzyme lecithin-cholesterol acyl-transferase.
Salvatore A; Cigliano L; Bucci EM; Corpillo D; Velasco S; Carlucci A; Pedone C; Abrescia P
Biochemistry; 2007 Oct; 46(39):11158-68. PubMed ID: 17824618
[TBL] [Abstract][Full Text] [Related]
11. Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease from Mild Cognitive Impairment.
Bermejo P; Martín-Aragón S; Benedí J; Susín C; Felici E; Gil P; Ribera JM; Villar AM
Free Radic Res; 2008 Feb; 42(2):162-70. PubMed ID: 18297609
[TBL] [Abstract][Full Text] [Related]
12. Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD.
Sultana R; Boyd-Kimball D; Poon HF; Cai J; Pierce WM; Klein JB; Merchant M; Markesbery WR; Butterfield DA
Neurobiol Aging; 2006 Nov; 27(11):1564-76. PubMed ID: 16271804
[TBL] [Abstract][Full Text] [Related]
13. High-density lipoprotein from hypercholesterolemic animals has peroxidized lipids and oligomeric apolipoprotein A-I: its putative role in atherogenesis.
Artola RL; Conde CB; Bagatolli L; Pécora RP; Fidelio GD; Kivatinitz SC
Biochem Biophys Res Commun; 1997 Oct; 239(2):570-4. PubMed ID: 9344872
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid, serum and plasma protein oxidation in Alzheimer's disease.
Korolainen MA; Pirttilä T
Acta Neurol Scand; 2009 Jan; 119(1):32-8. PubMed ID: 18547271
[TBL] [Abstract][Full Text] [Related]
15. Vitamin E in neurodegenerative disorders: Alzheimer's disease.
Kontush K; Schekatolina S
Ann N Y Acad Sci; 2004 Dec; 1031():249-62. PubMed ID: 15753151
[TBL] [Abstract][Full Text] [Related]
16. CSF lipoproteins and Alzheimer's disease.
Neely MD; Montine TJ
J Nutr Health Aging; 2002; 6(6):383-91. PubMed ID: 12459889
[TBL] [Abstract][Full Text] [Related]
17. Decreased plasma antioxidants in patients with Alzheimer's disease.
Kim TS; Pae CU; Yoon SJ; Jang WY; Lee NJ; Kim JJ; Lee SJ; Lee C; Paik IH; Lee CU
Int J Geriatr Psychiatry; 2006 Apr; 21(4):344-8. PubMed ID: 16534775
[TBL] [Abstract][Full Text] [Related]
18. Effects of short-term and long-term danazol treatment on lipoproteins, coagulation, and progression of atherosclerosis: two clinical trials in healthy volunteers and patients with hereditary angioedema.
Birjmohun RS; Kees Hovingh G; Stroes ES; Hofstra JJ; Dallinga-Thie GM; Meijers JC; Kastelein JJ; Levi M
Clin Ther; 2008 Dec; 30(12):2314-23. PubMed ID: 19167590
[TBL] [Abstract][Full Text] [Related]
19. Increase in the oxidized/total coenzyme Q-10 ratio in the cerebrospinal fluid of Alzheimer's disease patients.
Isobe C; Abe T; Terayama Y
Dement Geriatr Cogn Disord; 2009; 28(5):449-54. PubMed ID: 19907182
[TBL] [Abstract][Full Text] [Related]
20. Oxidation of thiol-proteases in the hippocampus of Alzheimer's disease.
Marcum JL; Mathenia JK; Chan R; Guttmann RP
Biochem Biophys Res Commun; 2005 Aug; 334(2):342-8. PubMed ID: 16018967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
